Ebolavirus comparative genomics

FEMS Microbiology Reviews

Volumn 39, Issue 5, 2015, Pages 764-778

  Jun, Se Ran ^a,b   Leuze, Michael R ^a   Nookaew, Intawat ^a   Uberbacher, Edward C ^a   Land, Miriam ^a   Zhang, Qian ^a,b   Wanchai, Visanu ^a   Chai, Juanjuan ^a   Nielsen, Morten ^c,d   Trolle, Thomas ^c   Lund, Ole ^c   Buzard, Gregory S ^e   Pedersen, Thomas D ^c,f   Wassenaar, Trudy M ^g   Ussery, David W ^a,b,c  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

^e Booz Allen and Hamilton Inc   (United States)

^f CHR HANSEN A S   (Denmark)

^g Molec Microbiol/Genom Consultants   (Germany)

Author keywords

Comparative genomics; Ebola; Ebola virus disease (EVD); Epitope prediction; Filovirus; Viral genomes

Indexed keywords

EPITOPE; GLYCOPROTEIN; NUCLEOPROTEIN; PROTEOME; SPACER DNA; VIRUS DNA; VIRUS PROTEIN;

ALLELE; B LYMPHOCYTE; BINDING SITE; CD34 SELECTION; EBOLAVIRUS; EPIDEMIC; FILOVIRUS; GENE ORDER; GENE STRUCTURE; GLYCOSYLATION; HLA SYSTEM; HUMORAL IMMUNITY; MARBURGVIRUS; NONHUMAN; PHYLOGENETIC TREE; PHYLOGENETIC TREE ROOT; PHYLOGENY; PROTEIN FUNCTION; PUBLICATION; REVIEW; T LYMPHOCYTE; VIRUS GENOME; VIRUS STRAIN; FILOVIRIDAE; GENETICS; GENOMICS;

EBOLAVIRUS; FILOVIRIDAE; GENOME, VIRAL; GENOMICS;

EID: 84947580321     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1093/femsre/fuv031     Document Type: Review

References (75)

1. Adu-Gyamfi E, Soni SP, Jee CS, et al. A loop region in the Nterminal domain of Ebola virus VP40 is important in viral assembly, budding, and egress. Viruses 2014;6:3837-54.
2. Audet J, Kobinger G. Immune evasion in Ebolavirus infections. Viral Immunol 2014;28:10-8.
3. Audet J, Wong G, Wang H, et al. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus. Sci Rep 2014;4:6881.
4. Bale S, Dias JM, Fusco ML, et al. Structural basis for differential neutralization of Ebolaviruses. Viruses 2012;4:447-70.
5. Becquart P, Mahlakoiv T, Nkoghe D, et al. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus. PloS One 2014;9:e96360.
6. Belyi VA, Levine AJ, Skalka AM. Unexpected inheritance: multiple integrations of ancient bornavirus and Ebolavirus/Marburgvirus sequences in vertebrate genomes. PloS Pathog 2010;6:e1001030.
7. Buggert M, Norström MM, Czarnecki C, et al. Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage. PLoS One 2012;7:e39874.
8. Carroll SA, Towner JS, Sealy TK, et al. Molecular evolution of viruses of the family filoviridae based on 97 whole-genome sequences. J Virol 2013;87:2608-16.
9. CDC Outbreaks Chronology. Ebola Virus Disease. Centers for Disease Control and Prevention, 2015. http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html (17 June 2015, date last accessed)
10. Corum J. A history of Ebola in 24 outbreaks. The New York Times, 2014.
11. Darriba D, Taboada GL, Doallo R, et al. ProtTest 3: fast selection of best-fit models of protein evolution. Bioinformatics 2011;27:1164-5.
12. Darriba D, Taboada GL, Doallo R, et al. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods 2012;9:772.
13. de La Vega M-A, Wong G, Kobinger GP, et al. The multiple roles of sGP in Ebola pathogenesis. Viral Immunol 2015;28:3-9.
14. Dudas G, Rambaut A. Phylogenetic analysis of Guinea 2014 EBOV Ebolavirus outbreak. PLoS Curr 2014;6.
15. Edgar RC. Search and clustering orders ofmagnitude faster than BLAST. Bioinformatics 2010;26:2460-1.
16. Finn RD, Clements J, Eddy SR. HMMER web server: interactive sequence similarity searching. Nucleic Acids Res 2011;39: W29-37.
17. Gascuel O. BIONJ: an improved version of the NJ algorithm based on a simple model of sequence data. Mol Biol Evol 1997;14:685-95.
18. Gebreyes W, Dupouy-Camet J, Newport M, et al. The global one health paradigm: challenges and opportunities for tackling infectious diseases at the human, animal, and environment interface in low-resource settings. PLoS Negl Trop D 2014;8:e3257.
19. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014;345:1369-72.
20. Gonzalez-Galarza FF, Christmas S, Middleton D, et al. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011;39:D913-9.
21. Guindon S, Dufayard JF, Lefort V, et al. Newalgorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010;59:307-21.
22. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003;52:696-704.
23. Hunter S, Apweiler R, Attwood TK, et al. InterPro: the integrative protein signature database. Nucleic Acids Res 2009;37:D211-5.
24. Ito K, Zeugmann T, Zhan JJ. Clustering the normalized compression distance for influenza virus data. In: Elomaa T, Mannila H, Orponen P (eds). Algorithms and Applications. Berlin: Springer, 2010, 130-46.
25. Jones P, Binns D, Chang HY, et al. InterProScan 5: genome-scale protein function classification. Bioinformatics 2014;30:1236-40.
26. Jun SR, Sims GE, Wu GHA, et al. Whole-proteome phylogeny of prokaryotes by feature frequency profiles: an alignment-free method with optimal feature resolution. P Natl Acad Sci USA 2010;107:133-8.
27. Kamata T, Natesan M, Warfield K, et al. Determination of specific antibody responses to the six species of ebola and marburg viruses by multiplexed protein microarrays. Clin Vaccine immunol 2014;21:1605-12.
28. Karosiene E, Lundegaard C, Lund O, et al. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions. Immunogenetics 2012;64:177-86.
29. Karosiene E, Rasmussen M, Blicher T, et al. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLADP and HLA-DQ. Immunogenetics 2013;65:711-24.
30. Katoh K, Standley DM. MAFFT Multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 2013;30:772-80.
31. Kim Y, Ponomarenko J, Zhu ZY, et al. Immune epitope database analysis resource. Nucleic Acids Res 2012;40:W525-30.
32. Kuhn JH, Andersen KG, Baize S, et al. Nomenclature-and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses 2014;6:4760-99.
33. Kuhner MK, Felsenstein J. Simulation comparison of phylogeny algorithms under equal and unequal evolutionary rates. Mol Biol Evol 1994;11:459-68.
34. Kurtz S, Phillippy A, Delcher AL, et al. Versatile and open software for comparing large genomes. Genome Biol 2004;5:R12.
35. Lee JE, Fusco ML, Hessell AJ, et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008a;454:177-82.
36. Lee JE, Kuehne A, Abelson DM, et al. Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda(x) light chain. JMol Biol 2008b;375:202-16.
37. Lee JE, Saphire EO. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol 2009;4:621-35.
38. Lennemann NJ, Rhein BA, Ndungo E, et al. Comprehensive functional analysis of N-Linked glycans on Ebola virus GP1. MBio 2014;5:e00862-13.
39. Liang HW, Zhou Z, Zhang SY, et al. Identification of Ebola virus microRNAs and their putative pathological function. Sci China Life Sci 2014;57:973-81.
40. Maganga GD, Kapetshi J, Berthet N, et al. Ebola virus disease in the Democratic Republic of Congo. New Engl J Med 2014;371:2083-91.
41. Mühlberger E. Filovirus replication and transcription. Future Virol 2007;2:205-15.
42. Mylne A, Brady OJ, Huang Z, et al. A comprehensive database of the geographic spread of past human Ebola outbreaks. Sci Data 2014;1:140042.
43. Negredo A, Palacios G, Vazquez-Moron S, et al. Discovery of an ebolavirus-like filovirus in Europe. PloS Pathog 2011;7:e1002304.
44. Nielsen M, Lundegaard C, Lund O, et al. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 2005;57:33-41.
45. Nkoghe D, Formenty P, Leroy EM, et al. Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002. Bull Soc Pathol Exot 2005;98:224-9.
46. Olival KJ, Hayman DT. Filoviruses in bats: current knowledge and future directions. Viruses 2014;6:1759-88.
47. Pattyn S, van der Groen G, Jacob W, et al. Isolation of Marburglike virus from a case of haemorrhagic fever in Zaire. Lancet 1977;1:573-4.
48. Paul S, Weiskopf D, Angelo MA, et al. HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. Immunol 2013;191:5831-9.
49. Plowright RK, Eby P, Hudson P, et al. Ecological dynamics of emerging bat virus spillover. Proc Biol Sci 2015;282:20142124.
50. Pringle CR. Order mononegavirales. In: Fauquet CM, Mayo MA, Maniloff J, et al. (eds) Virus Taxonomy: Eighth Report of the International Comittee on Taxonomy of Viruse. San Diego: Elsevier Academic Press, 2005, 609-66.
51. Qiu XG, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014;514:47-53.
52. Rosa M, Rizzo R, Urso A, et al. Comparison of genomic sequences clustering using normalized compression distance and evolutionary distance. In: Ignac Lovrek, Robert J.Howlett, Lakhmi C. Jain (eds). Knowledge-Based Intelligent Information and Engineering Systems, Berlin: Springer, 2008, 740-6.
53. Sanchez A, Trappier SG, Mahy BWJ, et al. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. P Natl Acad Sci USA 1996;93:3602-7.
54. Schubert B, Lund O, Nielsen M. Evaluation of peptide selection approaches for epitope-based vaccine design. Tissue Antigens 2013;82:243-51.
55. Shabman RS, Jabado OJ, Mire CE, et al. Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells. MBio 2014;5:e02011.
56. Shahhosseini S, Das D, Qiu X, et al. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens. J Virol Methods 2007;143:29-37.
57. Sheng MM, Zhong Y, Chen Y, et al. Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro. Sci China Life Sci 2014;57:959-72.
58. Siegert R, Shu HL, Slenczka W, et al. Zur ätiologie einer unbekannten, von Affen ausgegangenen menschlichen Infektionskrankheit. Deut Med Wochenschr 1967;92:2341-3.
59. Sobarzo A, Groseth A, Dolnik O, et al. Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan Ebolavirus (Gulu). J Infect Dis 2013;208:299-309.
60. Soni SP, Adu-Gyamfi E, Yong SS, et al. The Ebola virus matrix protein deeply penetrates the plasma membrane: an important step in viral egress. Biophys J 2013;104:1940-9.
61. Stranzl T, Larsen MV, Lundegaard C, et al. NetCTLpan: panspecific MHC class I pathway epitope predictions. Immunogenetics 2010;62:357-68.
62. Takada A, Ebihara H, Feldmann H, et al. Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis 2007;196:S347-56.
63. Taylor DJ, Ballinger MJ, Zhan JJ, et al. Evidence that ebolaviruses and cuevaviruses have been diverging from marburgviruses since the Miocene. PeerJ 2014;2:e556.
64. Trolle T, Nielsen M. NetTepi: an integrated method for the prediction of T cell epitopes. Immunogenetics 2014;66:449-56.
65. Tsuda Y, Caposio P, Parkins CJ, et al. A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus. Plos Neglect Trop D 2011;5:e1275.
66. van Noort V, Worning P, Ussery DW, et al. Strand misalignments lead to quasipalindrome correction. Trends Genet 2003;19:365-9.
67. Volchkov VE, Becker S, Volchkova VA, et al. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 1995;214:421-30.
68. Wang Y, Liu Z, Dai Q. A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody. Virus Res 2014;189:254-61.
69. Wilson JA, Hevey M, Bakken R, et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science 2000;287:1664-6.
70. Wittmann TJ, Biek R, Hassanin A, et al. Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants. P Natl Acad Sci USA 2007;104:17123-7.
71. Wong G, Kobinger GP, Qiu X. Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol 2014;10:781-90.
72. Wu GA, Jun SR, Sims GE, et al. Whole-proteome phylogeny of large dsDNA virus families by an alignment-free method. P Natl Acad Sci USA 2009;106:12826-31.
73. Wu SP, Yu T, Song XH, et al. Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins. Virol J 2012;9:111.
74. Wynne JW, Wang LF. Bats and viruses: friend or foe? PloS Pathog 2013;9:e1003651.
75. Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999;17:51-88.